Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT00788918
Eligibility Criteria:
Inclusion Criteria:
* Chronic HCV infection with genotype 1, 2, 3 or 4.
* Age \> 18 and \<60
* Liver biopsy or fibroscan performed within last 5 years
* Signed informed consent form.
Exclusion Criteria:
* Liver biopsy showing liver pathology not due to HCV infection.
* Liver cirrhosis or severe liver fibrosis
* Former antiviral HCV treatment (for included HCV patients).
* HIV and/or Hepatitis B virus infection.
* Alcohol or drug abuse within the last 2 years.
* Neutropenia, anemia or thrombocytopenia.
* Clinical signs of non-compensated liver pathology.
* Moderate to severe cardiopulmonary disease (NYHA score 1 or above)
* Creatinine clearance \< 80mL/min.
* Pregnancy.
* Ferromagnetic implants
* Significant somatic disease affecting the central nervous system (somatic/neurologic disease)
* Head trauma resulting in unconsciousness \> 5min
* Schizophrenia or other psychotic disorders
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00788918
Study Brief:
Protocol Section:
NCT00788918